Precigen, Inc.
PGENNasdaqCIK 1356090HealthcareFiscal year ends Dec 31
Reports and events: 290 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0416:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001356090-26-000030 |
| 2026-08-0416:05 ET | 8-K | 2.02 Results of operations | 0000950103-26-011876 |
| 2026-06-2416:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950103-26-009441 |
| 2026-05-1316:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-26-007158 |
| 2026-05-1316:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001356090-26-000017 |
| 2026-04-3016:06 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001140361-26-018214 |
| 2026-03-3116:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-037403 |
| 2026-03-2516:54 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001356090-26-000009 |
| 2026-03-2516:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-26-004648 |
| 2025-11-2120:23 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-113780 |
| 2025-11-1316:20 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001356090-25-000034 |
| 2025-11-1316:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-25-014683 |
| 2025-09-1920:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-089729 |
| 2025-09-1716:58 ET | 8-K | 3.02 Unregistered sale of equity | 0000950103-25-011775 |
| 2025-09-0307:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-086669 |
| 2025-08-1817:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950103-25-010408 |
| 2025-08-1808:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-079497 |
| 2025-08-1216:29 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001356090-25-000024 |
| 2025-06-3016:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950103-25-008124 |
| 2025-05-1616:03 ET | DEF 14A | Proxy statementPeriod 2025-06-26 | 0001140361-25-019470 |
| 2025-05-1416:23 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001356090-25-000019 |
| 2025-05-1416:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-25-006004 |
| 2025-04-2817:23 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001356090-25-000011 |
| 2025-03-1916:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001356090-25-000007 |
| 2025-03-1916:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-25-003637 |
| 2025-01-1616:07 ET | 8-K | 8.01 Other events | 0000950103-25-000576 |
| 2024-12-3019:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-24-113602 |
| 2024-12-3016:18 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-24-018479 |
| 2024-12-2616:40 ET | 8-K | 1.01 Entry into a material agreement | 0000950103-24-018350 |
| 2024-11-1416:52 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001356090-24-000026 |
| 2024-11-1416:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-24-016317 |
| 2024-11-0716:05 ET | 8-K | 3.01 Delisting notice | 0000950103-24-016076 |
| 2024-10-1016:33 ET | 8-K | 1.02 Termination of a material agreement | 0000950103-24-014811 |
| 2024-09-2319:44 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950103-24-013816 |
| 2024-08-3017:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950103-24-012981 |
| 2024-08-1416:25 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001356090-24-000017 |
| 2024-08-1416:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-24-012201 |
| 2024-08-1316:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-068241 |
| 2024-08-0909:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-087596 |
| 2024-08-0616:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-086275 |
| 2024-07-0517:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950103-24-009693 |
| 2024-05-2816:44 ET | DEF 14A | Proxy statementPeriod 2024-07-05 | 0001104659-24-065631 |
| 2024-05-1417:23 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001356090-24-000010 |
| 2024-05-1417:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-24-006675 |
| 2024-05-0320:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-039858 |
| 2024-04-2916:05 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001104659-24-054003 |
| 2024-03-1916:48 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001356090-24-000007 |
| 2024-03-1916:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-24-004017 |
| 2024-02-0816:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950103-24-001932 |
| 2024-01-0808:39 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-24-000379 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.